GLP3-RT/ Cag 5/5mg
Dual-Pathway Metabolic Signaling Research Blend | Laboratory Use Only
This co-formulated research blend pairs retatrutide, a synthetic peptide studied as a triple agonist at the GIP, GLP-1, and glucagon receptors, with cagrilintide, a long-acting amylin analogue. It is supplied for laboratory studies of overlapping incretin and amylin signaling pathways in controlled experimental systems.
$168.00
Availability: 21 in stock
Product Overview
- Components: Retatrutide (39-residue peptide) and cagrilintide (32-residue peptide)
- Common strengths: 12.5 mg / 2.5 mg or 5 mg / 5 mg per vial (confirm yours)
- Format: Lyophilized powder in a sealed vial
- Purity: Typically ≥98% to ≥99% by HPLC, with mass spectrometry identity confirmation
- Documentation: Lot-matched COA; sequences and characterization per COA
Research Areas of Interest
- GIP, GLP-1, and glucagon receptor signaling
- Amylin receptor signaling
- Interaction between incretin and amylin pathways in cell-based and preclinical models
- Analytical method development and peptide stability
Storage and Handling
Store in a dry, cool, dark place. Follow the temperature range on your COA or label (commonly 4 °C to −20 °C). Handle only in a laboratory setting by qualified personnel.Important Notice
For laboratory research use only. Not for human or veterinary use, not a drug or dietary supplement, and not intended to diagnose, treat, cure, or prevent any disease. Sold only to qualified researchers and institutions aged 18 and over. The purchaser is responsible for legal and compliant use.Related Products
